|
Current issue
Archive
Videos
Articles in press
About the journal
Supplements
Editorial board
Reviewers
Abstracting and indexing
Subscription
Contact
Instructions for authors
Publication charge
Ethical standards and procedures
Editorial System
Submit your Manuscript
|
1/2018
vol. 120 abstract:
Review paper
Anti-retinal antibodies as an etiopathogenetic factor and markers of retinal damage in diseases of the posterior segment of the eye
Monika Węglarz
,
Izabella Karska-Basta
,
Agnieszka Kubicka-Trząska
,
Bożena Romanowska-Dixon
Online publish date: 2018/07/10
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Retinal autoimmunity has been recently thoroughly investigated. The presence of anti- retinal antibodies in sera from patients with retinal damage due to cancer-associated retinopathy, melanoma-associated retinopathy, presumed non-paraneoplastic autoimmune retinopathy, uveitis, age-related macular degeneration, retinitis pigmentosa, idiopathic retinopathies, proliferative vitreoretinopathies as well as in wide range of the systemic autoimmune diseases without visual symptoms has been documented. There is still debate whether anti-retinal antibodies are directly involved in the etiopathogenesis of retinal damage or represent only an epiphenomenon related to the tissue damage due to some other aetiology. The authors review the current literature regarding the occurrence and potential significance of anti-retinal antibodies in etiopathogenesis and diagnosis of the posterior segment eye diseases.
keywords:
anti-retinal antibodies, biomarkers of retinal damage, autoimmune retinopathies, autoimmune retinal damage |
|
POLSKI
